Barclays Maintains Equal-Weight on Sabra Health Care REIT, Lowers Price Target to $21

Benzinga · 2d ago
Barclays analyst Richard Hightower maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Equal-Weight and lowers the price target from $23 to $21.